ClinicalTrials.Veeva

Menu

Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's Disease (CYCLE)

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Parkinson Disease

Treatments

Dietary Supplement: Electrolyte Beverage
Dietary Supplement: Ketone Ester Beverage
Behavioral: Cycling Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05948956
HUM00232413

Details and patient eligibility

About

The main purpose of this study is to assess changes in exercise capacity in people with Parkinson's disease before and after an exercise training program with ketone ester supplementation.

Enrollment

20 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Parkinson's Disease

Exclusion criteria

  • Any recent changes in EKG, history of myocardial infarction or other cardiac event or other cardiac contraindications to exercise
  • Inability to use a step, stand, walk, or use a stationary cycle ergometer
  • History of symptoms in exercise that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain, painful neuropathy, significant ankle edema or medication side effects
  • History of symptomatic cardiovascular or pulmonary disease interfering with exercise
  • History of active rheumatoid arthritis
  • History of uncontrolled chronic pain syndrome
  • Any other history of medical or psychiatric comorbidity precluding safe participation in the project
  • Poorly controlled diabetes
  • Pregnancy or breastfeeding
  • Clinically significant dementia
  • Any contraindications to MRI (metal implants, severe claustrophobia, inability to lie still for 1 hour, etc.)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

20 participants in 4 patient groups, including a placebo group

5-Session Ketone Ester Beverage & Exercise
Experimental group
Description:
Participants will consume ketone ester (KE) beverage, consisting of 2 scoops (=25 g C8-KE) of Qitone Pro-Ketone Powder™ and electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise.
Treatment:
Behavioral: Cycling Intervention
Dietary Supplement: Ketone Ester Beverage
5-Session Electrolyte Beverage & Exercise
Placebo Comparator group
Description:
Participants will consume placebo electrolyte (EL) beverage, consisting of an electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise
Treatment:
Behavioral: Cycling Intervention
Dietary Supplement: Electrolyte Beverage
12-Session Ketone Ester Beverage & Exercise
Experimental group
Description:
Participants will consume ketone ester (KE) beverage, consisting of 2 scoops (=25 g C8-KE) of Qitone Pro-Ketone Powder™ and electrolyte solution diluted in water, before each of 12 1-hour sessions of aerobic exercise.
Treatment:
Behavioral: Cycling Intervention
Dietary Supplement: Ketone Ester Beverage
12-Session Electrolyte Beverage & Exercise
Placebo Comparator group
Description:
Participants will consume placebo electrolyte (EL) beverage, consisting of an electrolyte solution diluted in water, before each of 12 1-hour sessions of aerobic exercise
Treatment:
Behavioral: Cycling Intervention
Dietary Supplement: Electrolyte Beverage

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Austin Luker, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems